化疗对正常血细胞的长期影响
Emily Mitchell1,2,3, My H Pham1, Anna Clay2,4
1Wellcome Sanger Institute, Hinxton, UK.
Nature genetics
|July 2, 2025
概括
化疗可以导致显著的DNA损伤和改变血液细胞群,模仿衰老效应. 了解这些长期影响对于管理癌症治疗副作用至关重要.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 毒理学 毒理学 毒理学
背景情况:
- 化疗剂旨在诱导癌细胞中的DNA损伤.
- 在正常组织中,化疗诱导的附带DNA损伤的长期影响尚不清楚.
研究的目的:
- 研究化疗对正常组织突变负荷的影响.
- 分析化疗后正常血液细胞群结构的变化.
主要方法:
- 来自23名 (年龄为3至80岁) 用各种化疗方案治疗的个体的血液细胞的基因组测序.
- 实体突变负载和突变特征的分析.
- 细胞群结构变化的评估.
主要成果:
- 一些化疗剂显著增加了具有明显特征的体质突变负载.
- 化疗诱导的效果因特定药物和血细胞类型而异.
- 化疗加速了正常血细胞群结构的变化,类似于正常的衰老.
结论:
- 化疗可以对正常组织造成重大长期生物后果.
- 这些发现强调了需要了解这些不良影响背后的机制.
- 有机会减轻细胞毒性化疗的长期负面影响.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265


